Inventory / revenue moved 1685 bp higher
Inventory / revenue changed +1685 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +1685 basis points from the comparable as-filed period.
Inventory changed +23.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -1674 basis points from the comparable as-filed period.
Receivables / revenue changed -2044 basis points from the comparable as-filed period.
Current ratio changed -12.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.